Skip to main content
. Author manuscript; available in PMC: 2021 Aug 1.
Published in final edited form as: Ann Thorac Surg. 2020 Apr 3;110(2):414–423. doi: 10.1016/j.athoracsur.2020.02.061

Table 2.

Sub distribution Hazard model of waitlist mortality.

Hazard Ratio 95% Cl p-value
Sensitization
 No UA-HLA Data Reported Reference Reference Reference
 CPRA < 50 0.84 0.756 to 0.933 0.001
 CPRA ≥ 50 1.71 1.553 to 1.883 < 0.001
Gender
 Female Reference Reference Reference
 Male 0.709 0.663 to 0.758 < 0.001
Age at Listing, by Year 0.999 0.993 to 1.006 0.086
LAS at Listing 1.02 1.015 to 1.026 < 0.001
Primary Diagnosis
 Group A Reference Reference Reference
 Group B 2.151 1.861 to 2.487 < 0.001
 Group C 1.197 1.041 to 1.375 0.011
 Group D 1.732 1.601 to 1.874 < 0.001
ECMO at Registration 1.094 0.869 to 1.377 0.45
Ventilator at Registration 3.439 2.995 to 3.949 < 0.001
Blood Type
 Type A Reference Reference Reference
 Type AB 0.994 0.832 to 1.187 0.94
 Type B 1.136 1.022 to 1.261 0.18
 Type O 1.122 1.048 to 1.202 0.001